SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001992
Filing Date
2022-07-28
Accepted
2022-07-28 16:17:53
Documents
58
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220531x10q.htm   iXBRL 10-Q 1606289
2 EX-31.1 tmb-20220531xex31d1.htm EX-31.1 15130
3 EX-32.1 tmb-20220531xex32d1.htm EX-32.1 5732
  Complete submission text file 0001410578-22-001992.txt   6130396

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20220531.xsd EX-101.SCH 50339
5 EX-101.CAL tmb-20220531_cal.xml EX-101.CAL 31887
6 EX-101.DEF tmb-20220531_def.xml EX-101.DEF 201948
7 EX-101.LAB tmb-20220531_lab.xml EX-101.LAB 400678
8 EX-101.PRE tmb-20220531_pre.xml EX-101.PRE 307994
52 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220531x10q_htm.xml XML 1006984
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 221115438
SIC: 2834 Pharmaceutical Preparations